ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01113281
Recruitment Status : Completed
First Posted : April 29, 2010
Last Update Posted : November 21, 2011
Sponsor:
Collaborators:
Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site)
Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study)
University of Stellenbosch
HJ-CTC George, RSA (Statistics & Report)
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : March 2011